|
" Acute leukemias II : "
editors: T. Büchner a.o.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
723780
|
| Doc. No
|
:
|
b543496
|
| Main Entry
|
:
|
editors: T. Büchner a.o.
|
| Title & Author
|
:
|
Acute leukemias II : : Prognostic factors and treatment strategies\ editors: T. Büchner a.o.
|
| Publication Statement
|
:
|
Berlin: Springer-Verlag, 1990
|
| Series Statement
|
:
|
Haematology and blood transfusion, 33
|
| Page. NO
|
:
|
xxxi, 776 sider
|
| ISBN
|
:
|
3540509844
|
|
|
:
|
: 9783540509844
|
| Contents
|
:
|
Leukemia Cell Biology and Basic Science.- Myelodysplastic Syndromes: Preleukemic or Early Leukemic Conditions?.- Mechanisms of Autocrine and Paracrine Growth Control in Acute Myelogenous Leukemia.- Clonal Analysis of Human Leukemias by Molecular Genetic Approaches.- Clinical Relevance of Cytogenetics in Acute Leukemia.- Minimal Residual Disease in Acute Leukemia: Lessons Learned from Animal Models.- Toward Improvement of Therapeutic Strategies in Leukemia by Amplification of the Immune Response Against Leukemia.- Double Marker Analysis for Terminal Deoxynucleotidyl Transferase and Myeloid Antigens in Acute Nonlymphocytic Leukemia Patients and Healthy Subjects.- Antigen Receptor Rearrangement and Expression in Acute Leukemias.- Immunoglobulin and T-Cell Receptor Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma.- Heterogeneity in Protein Patterns of CGL Blast Crisis Cells: Discrimination Between Lymphatic and Myeloic Lineages.- Correlation Between the Expression of Myelomonocytic Surface Antigens and Ultrastructural Demonstration of Early Myeloperoxidase Expression in Null-AL (L) Cells.- Interleukin-1 Production in Childhood Acute Lymphoblastic Leukemia During Chemo- and Radiotherapy According to BFM (Berlin-Frankfurt-Munster) Protocol.- Determination of Soluble Interleukin-2 Receptors After Bone Marrow Transplantation.- Synergism of H2-Histamine Receptor Antagonists with Alpha-Interferon to Inhibit the Growth of Leukemic and Normal Hematopoietic Progenitors.- Dependence of Serum Erythropoietin Level on Erythropoiesis in Leukemia.- Transferrin Derivatives with Growth Factor Activities in Acute Myeloblastic Leukemia: An Autocrine/Paracrine Pathway.- In Vitro Effects of G-CSF, GM-CSF, and IL-3 on Leukemic Cells of Children with Acute Nonlymphoblastic Leukemia.- In Vitro Growth Kinetics of Myeloid Progenitors Cells of Myelodysplastic Patients in Response to Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3.- Lymphokine-Activated Killer (LAK) Cells Against Human Leukemia: Augmentation of LAK-Cell Cytotoxicity by Combinations of Lymphokines or Cytokines.- Biochemical Evidence for Synergistic Combination Treatment with Methotrexate and 6-Mercaptopurine in Acute Lymphoblastic Leukemia.- Pharmacokinetics of Folinic Acid in Children with Acute Lymphoblastic Leukemia.- Cellular Pharmacokinetics of Daunomycin in Human Leukemic Blasts In Vitro and In Vivo.- Synergistic Cytotoxicity of Cystosine Arabinoside and Mitoxantrone for K562 and CFU-GM.- Mafosfamide Induces Less Sister Chromatid Exchange in Ph-Positive Cells Than in Normal Bone Marrow.- Blood Concentration of Ascorbyl-Free Radical in Children with Acute Lymphoblastic Leukemia: Preliminary Report.- Association of GP40/CD7+ Acute Myeloblastic Leukemia and Chromosome 5 Aberrations.- Acute Monocytic Leukemia with Translocation t(1;11) (p31;q23): Simultaneous Staining of Chromosomes and Cell Surface Antigens.- Prognostic Significance of Chromosome Analysis in De Novo Acute Myeloid Leukemia.- Chromosomal Aberrations in Childhood Acute Nonlymphoblastic Leukemia.- Cytogenetic Study of 130 Childhood Acute Nonlymphocytic Leukemias.- Changes in Clonal Growth, Immunophenotype, and Morphology During a Follow-up Study of an Acute Lymphoblastic Leukemia.- Prognostic Significance of the Karyotype in Patients with Primary Myelodysplastic Syndrome.- Update of the Cytogenetic Study of Childhood Non-High-Risk Acute Lymphocytic Leukemia at Diagnosis in Protocol VI of the Dutch Childhood Leukemia Study Group.- Prognosis and DNA Aneuploidy in Children with Acute Lymphoblastic Leukemia.- Acute Myelogenous Leukemia in Children.- Improved Treatment Results in the Myelocytic Subtypes FAB M1-M4 but not in FAB M5 After Intensification of Induction Therapy: Results of the German Childhood AML Studies BFM-78 and BFM-83.- Intensive Sequential Chemotherapy for Children with Acute Myelogenous Leukemia.- Therapy of Childhood Acute Nonlymphocytic Leukemia: The Pediatric Oncology Group Experience (1977-1988).- Preliminary Results of Intensive Therapy of Children and Adolescents with Acute Nonlymphocytic Leukemia - A Childrens Cancer Study Group Report.- High-Dose Ara-C as a Single-Agent Consolidation Therapy in Childhood Acute Myelogenous Leukemia.- Therapy of Childhood Acute Myelogenous Leukemia: An Update of the AIEOP/LAM 8204 Study.- Prognostic Significance of Eosinophilia in Acute Myelomonocytic Leukemia in Relation to Induction Treatment.- Treatment of Childhood Acute Nonlymphocytic Leukemia: Cooperative Austrian-Hungarian Study AML-IGCI-84.- Acute Myelogenous Leukemia in Adults.- Morphology, Immunology, Cytochemistry, and Cytogenetics and the Classification of Subtypes in Acute Myeloid Leukemia.- Remission Induction and Postremission Therapy in Acute Myelogenous Leukemia: British MRC Study.- Therapy of Acute Myelogenous Leukemia in Adults.- Consolidation Therapy with High-Dose Cytosine Arabinoside: Experiences of a Prospective Study in Acute Myeloid Leukemia.- Adult AML: The Role of Chemotherapy Intensity and Duration.
|
|
|
:
|
Two Studies of the AML Cooperative Group.- Comparison of Postremission Therapies in Adult Acute Myeloid Leukemia: Preliminary Analysis of an ECOG Study.- EORTC Leukemia Group Trials on Acute Myeloid Leukemias: An Overview.- A Randomized Comparison of Intensive Maintenance Treatment for Adult Acute Myelogenous Leukemia Using Either Cyclic Alternating Drugs or Repeated Courses of the Induction-Type Chemotherapy: AML-6 Trial of the EORTC Leukemia Cooperative Group.- Predictive Models for Achievement of Complete Remission and Duration of First Remission in Adult Acute Myeloid Leukemia.- Sequential Decision Strategy of the AML Cooperative Group Studies.- Pretherapeutic Drug Testing in Acute Leukemias for Prediction of Individual Prognosis.- Double Intensive Consolidation Chemotherapy (ICC) for Acute Myeloid Leukemia.- Intensive Induction Therapy with Behenoyl Cytosine Arabinoside, Danorubicin, and 6-Mercaptopurine Followed by Intensive Consolidation with Mitoxantrone, Etoposide, Vincristine, and Intermediate-Dose Continuous Cytarabine (M-85 Protocol) for Adult Acute Myelogenous Leukemia.- Acute Nonlymphocytic Leukemia in Adults: Results Obtained with TAD Remission Induction Therapy.- Combination Therapy with Mitoxantrone and Etoposide in Adult Acute Myelogenous Leukemia.- Combination of Mitoxantrone and Etoposide in Patients Aged over 60 Years with Untreated Acute Myelogenous Leukemia.- Mitoxantrone in the Treatment of Acute Leukemia.- Mitoxantrone, Cytosine Arabinoside, and VP-16 in 36 Patients with Relapsed and Refractory Acute Myeloid Leukemia.- Mitoxantrone and Etoposide in Patients with Relapsed and Refractory Acute Nonlymphocytic Leukemia.- Continuous Infusion of Mitoxantrone Combined with High-Dose Cytarabine in Refractory/Relapsed Acute Myeloblasts Leukemia and Blast Crisis of Chronic Myelogenous Leukemia.- Intermediate Dose Ara-C/m-AMSA for Remission Induction and High-Dose Ara-C/m-AMSA for Intensive Consolidation in Relapsed and Refractory Adult Acute Myelogenous Leukemia.- Treatment of Recurrent Acute Myelogenous Leukemia at a Single Centre Over a 10-Year Period.- Oral Idarubicin in Elderly Acute Leukemia and Refractory Anemia with Excess of Blasts.- Acute Promyelocytic Leukemia: Clinical Findings and Therapeutic Results in 30 Patients.- Magnetic Resonance Imaging Follow-up in Patients with Acute Leukemia During Induction Chemotherapy.- Thrombin Generation in Acute Myeloblastic Leukemia.- Acute Megakaryoblastic Leukemia: A Case Report.- Acute Megakaryoblastic Leukemia (FAB-M7) in an Infant Presenting with Orbital Chloroma and Meningeal Involvement.- Risk of Leukemic Transformation in Two Types of Acquired Idiopathic Sideroblastic Anemia.- Treatment of Advanced Myelodysplastic Syndromes: Trend Toward More Aggressive Chemotherapy?.- Chronic Myelomonocytic Leukemia: Clinical Data, Morphological Features, and Outcome in 56 Patients.- Chemotherapy of Acute Myeloid Leukemia of 35- to 60-Year-Old Patients.- Acute Lymphoblastic Leukemia in Adults.- Importance of Long-Term Follow-up in Evaluating Treatment Regimens for Adults with Acute Lymphoblastic Leukemia.- Comparison of Chemotherapy and Autologous and Allogeneic Transplantation as Postinduction Regimen in Adult Acute Lymphoblastic Leukemia: A Preliminary Multicentric Study.- Intensive Chemotherapy for Acute Lymphoblastic Leukemia in Adults.- Clinical Importance of T-ALL Subclassification According to Thymic or Pretyhmic Maturation Stage.- Treatment of Adult Acute Lymphoblastic Leukemia.- Treatment of Relapsed Acute Lymphocytic Leukemia in Adults.- Acute Lymphoblastic Leukemia in Children.- Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studies.- Cytogenetics of Childhood Acute Lymphoblastic Leukemia in German Multicenter Trials.- More is Better! Update of Dana-Farber Cancer Institute/Children's Hospital Childhood Acute Lymphoblastic Leukemia Trials.- Treatment of Acute Lymphoblastic Leukemia: Protocol Fralle 83-85.- Dutch Childhood Leukemia Study Group: Early Results of Study ALL VI (1984-1988).- Results of Acute Lymphoblastic Leukemia Therapy in Childhood: GDR-Experiences 1981-1987.- Impact of Early Intensive Reinduction Therapy on Event-Free Survival in Children with Low-Risk Acute Lymphoblastic Leukemia.- Improved Prognosis for Childhood Acute Lymphocytic Leukemia with Very High White Blood Cell Count (>100/nl) with Rotation of Non-Cross-Resistant Drug Combinations.- Prognosis of Initial CNS Involvement in Acute Lymphocytic Leukemia in Childhood.- Central Nervous System Relapse Prevention in 1165 Standard-Risk Children with Acute Lymphoblastic Leukemia in Five BFM Trials.- Effective Prevention of Central Nervous System Leukemia with Intrathecal Methotrexate and Intrathecal Methotrexate, Cytosine Arabinoside, and Hydrocortisone in Childhood Acute Lymphocytic Leukemia.- Risk of CNS Relapse After Systemic Relapse of Childhood Acute Lymphoblastic Leukemia.- Incidence and Clinical Implications of Acute Hybrid Leukemia in Childhood.- Supportive Care in Acute Leukemias.- Prevention of Infection in Acute Leukemia.- The Febrile Neutropenic Patient: Newer Options for Empirical Therapy.- Supportive Care of the Marrow Transplant Recipient: The Seattle Experience.- Management of Fungal Infection in Neutropenic Patients with Fluconazole.- Prevention of Bacteremias Caused by Hemolytic Streptococci by Roxithromycin in Patients Treated with Intensive Cytotoxic Treatment.- Hepatosplenic Candidosis in Acute Leukemias.- Effect of Antifungal Therapy on Hematological Recovery After Intensive Antileukemic Chemotherapy.- Preliminary Results of Treatment with Intraconazole in Patients with Systemic Fungal Infections.- Lymphocyte Contamination in Leukocyte-Depleted Red Cell and Platelet Concentrates Obtained by Filtration.- Effects of Verapamil on Anthracycline-Induced Cardiomyopathy: Preliminary Results of a Prospective Multicenter Trial.- Prospective Study on the Influence of Disease or Treatment on Pituitary Function in 31 Children with Acute Leukemia and Non-Hodgkin's Lymphoma.- Incidence of Aseptic Osteonecrosis Following the Therapy of Childhood Leukemia.- Osteoporosis in Children with Leukemia: A Potentially Debilitating Anomaly?.- Principles of Supportive Psychological Care for Patients Undergoing Bone Marrow Transplantation.- Fibronectin in Stomatitis Therapy of Leukemic Children.- Treatment of Relapse and Pharmacokinetics.- Karyotype of Leukemia Cells Consistently Predicts for Response to Therapy and Survival Following Salvage Therapy in Acute Myeloblastic Leukemia.- Proposal for the Classification of Relapsed and Refractory Acute Myeloid Leukemias as the Basis for an Age-Adjusted Randomized Comparison of Sequentially Applied High-Dose Versus Intermediate-Dose Cytosine Arabinoside in Combination with Mitoxantrone (S-HAM).- Pharmacologically Directed Design of Leukeumia Therapy.- Treatment of Relapsed or Refractory Acute Leukemia: Comparison of Two Different Regimens.- BFM Group Treatment Results in Relapsed Childhood Acute Lymphoblastic Leukemia.- Bone Marrow Transplantation.- Marrow Grafting for Acute Leukemia: Results and Future Treatment Strategies.- Bone Marrow Transplantation from Histocompatible Sibling Donors for Patients with Acute Lymphoblastic Leukemia.- Allogeneic Bone Marrow Transplantation in Childhood Leukemia: Results and Strategies in the Federal Republic of Germany.- Allogeneic and Autologous Bone Marrow Transplantation in Acute Leukemia: The Essen Experience.- Role of Cytokines and Major Histocompatibility Complex Antigens in Graft-Versus-Host Disease: In Vitro Studies Using T-Cell Lines and Keratinocytes or Hemopoietic Targets.- Autologous Bone Marrow Transplantation in Acute Myeloid Leukemia in First Remission: First Dutch Prospective Study.- Autologous Bone Marrow Transplantation for Acute Leukemia in Remission: An Analysis of 1322 Cases.- Role of Autologous Bone Marrow Transplantation in Acute Leukemia.- Long-Term Disease-Free Survival
|
|
|
:
|
Following Autologous Bone Marrow/Blood Stem Cell Transplantation in 89 Patients with Acute Leukemia.- Allogeneic and Autologous Bone Marrow Transplantation for Acute Lymphoblastic Leukemia.- Treatment Strategies for Acute Lymphoblastic Leukemia.- Influence of Treatment Modality, Patient/Donor Characteristics, and Disease Stage on the Risk of Relapse After Allogeneic Marrow Transplantation for Acute Leukemia.- Comparison of Allogeneic and Autologous Bone Marrow Transplantation for Treatment of Acute Lymphocytic Leukemia in Childhood.- High-Dose Chemotherapy with Noncryopreserved Autologous Bone Marrow Transplantation for Acute Myeloblastic Leukemia in First Complete Remission.- Myelopoietic Reconstitution Following Autologous Bone Marrow Transplantation.- Bone Marrow Transplantation with a Fixed Low Number of T-Cells in the Graft.- Complotyping and Subtyping of MHC Class I Gene Products in Haplotype Determination for Bone Marrow Transplantation.- Complications of Bone Marrow Transplantation in Chinese.- Hematopoietic Growth Factors.- Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Neutropenia and Related Morbidity Induced by Myelotoxic Chemotherapy.- Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor After Chemotherapy for Acute Leukemias at Higher Age or After Relapse.- Treatment of Poor-Prognosis, Newly Diagnosed Acute Myelogenous Leukemia with High-Dose Cytosine Arabinoside (Ara-C) and rHUGM-CSF.- Use of Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor to Speed Engraftment and Treat Graft Failure Following Marrow Transplantation in Man.- Regeneration of Granulopoiesis with Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor After Autologous Bone Marrow Transplantation.- Colony-Stimulating Factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCFG) Recruit Myeloblastic and Lymphoblastic Leukemic Cells and Enhance the Cytotoxic Effects of Cytosine-Arabinoside.- Effect of Treatment with rgGM-CSF and Low-Dose Cytosine Arabinoside on Leukemic Blast Cells in Patients with Myelodysplastic Syndromes.
|
| Subject
|
:
|
Acute leukemia
|
| Subject
|
:
|
Acute leukemia.
|
| Subject
|
:
|
Leukemia -- Treatment.
|
| LC Classification
|
:
|
RC643.E358 1990
|
| Added Entry
|
:
|
Th Büchner
|
| |